International union of basic and clinical pharmacology. CXII: adenosine receptors: a further update

AP IJzerman, KA Jacobson, CE Müller… - Pharmacological …, 2022 - Elsevier
Abstract Our previous International Union of Basic and Clinical Pharmacology report on the
nomenclature and classification of adenosine receptors (2011) contained a number of …

Biased receptor signaling in drug discovery

T Kenakin, EL Barker - Pharmacological reviews, 2019 - Elsevier
A great deal of experimental evidence suggests that ligands can stabilize different receptor
active states that go on to interact with cellular signaling proteins to form a range of different …

Historical and current adenosine receptor agonists in preclinical and clinical development

KA Jacobson, DK Tosh, S Jain, ZG Gao - Frontiers in cellular …, 2019 - frontiersin.org
Adenosine receptors (ARs) function in the body's response to conditions of pathology and
stress associated with a functional imbalance, such as in the supply and demand of …

Research progress on adenosine in central nervous system diseases

YJ Liu, J Chen, X Li, X Zhou, YM Hu… - CNS neuroscience & …, 2019 - Wiley Online Library
As an endogenous neuroprotectant agent, adenosine is extensively distributed and is
particularly abundant in the central nervous system (CNS). Under physiological conditions …

[HTML][HTML] Novel molecular mechanisms for the adaptogenic effects of herbal extracts on isolated brain cells using systems biology

A Panossian, EJ Seo, T Efferth - Phytomedicine, 2018 - Elsevier
Introduction Adaptogens are natural compounds or plant extracts that increase adaptability
and survival of organisms under stress. Adaptogens stimulate cellular and organismal …

The role of the adenosine system in epilepsy and its comorbidities

JA Baltos, PM Casillas‐Espinosa… - British Journal of …, 2024 - Wiley Online Library
Epilepsy is one of the most serious and common chronic neurological conditions,
characterised by recurrent hypersynchronous electrical activity in the brain that lead to …

New binding sites, new opportunities for GPCR drug discovery

HCS Chan, Y Li, T Dahoun, H Vogel, S Yuan - Trends in biochemical …, 2019 - cell.com
Many central biological events rely on protein–ligand interactions. The identification and
characterization of protein-binding sites for ligands are crucial for the understanding of …

Insights into biased signaling at cannabinoid receptors: synthetic cannabinoid receptor agonists

E Wouters, J Walraed, SD Banister, CP Stove - Biochemical pharmacology, 2019 - Elsevier
Abstract Cannabinoid receptors type 1 (CB 1) and type 2 (CB 2) are promising targets for a
number of diseases, including obesity, neuropathic pain, and multiple sclerosis, among …

Structural insights into the G protein selectivity revealed by the human EP3-Gi signaling complex

R Suno, Y Sugita, K Morimoto, H Takazaki, H Tsujimoto… - Cell Reports, 2022 - cell.com
Prostaglandin receptors have been implicated in a wide range of functions, including
inflammation, immune response, reproduction, and cancer. Our group has previously …

New paradigms in purinergic receptor ligand discovery

KA Jacobson, B Pradhan, Z Wen, A Pramanik - Neuropharmacology, 2023 - Elsevier
The discovery and clinical implementation of modulators of adenosine, P2Y and P2X
receptors (comprising nineteen subtypes) have progressed dramatically in∼ 50 years since …